| Roche Pharma (Schweiz) AG - Esbriet 267 mg, Filmtabletten | | 66422 | | 01 | | Esbriet 267 mg | | Filmtabletten | | L04AX05 | | Pirfenidone | | 08.11.2017 | | |
| | Composition | | Filmtablette: pirfenidonum 267 mg, cellulosum microcristallinum, silica colloidalis anhydrica, povidonum K 30, carmellosum natricum conexum corresp. natrium 0.39 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose | additional_information |
|---|
| Pirfenidonum | 267 mg | Filmtablette |
| | BAG: Active Agent | Dose |
|---|
| Pirfenidonum | 267 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 90 | 785.67 | 870.90 | B | SL | Yes |
|
|
